Abstract

Research Article

Intraperitoneal and Subsequent Intravenous Vancomycin: An Effective Treatment Option for Gram-Positive Peritonitis in Peritoneal Dialysis

Barone RJ*, Gimenez NS and Ramirez L

Published: 20 April, 2017 | Volume 1 - Issue 1 | Pages: 014-018

Intraperitoneal vancomycin absorption is higher when there is peritoneal inflammation, but the absorption decreases with recovery from peritonitis. Consequently, intraperitoneal maintenance doses are ineffective, reducing the rate of cure.

Aim:To evaluate the outcome of Gram-positive peritonitis treated with intraperitoneal and subsequent intravenous vancomycin.

Methods: In April 1996, we initiated a protocol for treating peritonitis caused by Gram-positive organisms using a 2-g intraperitoneal loading dose of vancomycin followed by intravenous vancomycin at 1 g twice in 5 days for coagulase-negative Staphylococcus and at 1 g three times in 5 days for Staphylococcus aureus. We analyzed episodes of Gram-positive peritonitis (coagulase-negative and S. aureus) and the efficiency of the treatment protocol in 113 patients undergoing peritoneal dialysis between 1 April, 1996 and 3 August, 2016. There were 6090 patient-months and the mean treatment lasted 54±44 months. The outcomes were evaluated as (1) complete cure, (2) relapsing peritonitis, (3) catheter removal for refractory peritonitis, and (4) death.

Results: A total of 51 cases of coagulase-negative Staphylococcus peritonitis and 37 of S. aureus were seen in 46 of the 113 patients (40.7%). Of these, coagulase-negative Staphylococcus (92.15%) and 34 S. aureus peritonitis (91.89%) resolved.

Conclusion:The response to treatment was very satisfactory.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001003 Cite this Article Read Full Article PDF

References

  1. Churchill DN, Taylor DW, Vas SI, The Canadian CAPD clinical Trial Group. Peritonitis in CAPD: A multi-centre randomised clinical trial comparing the y-connector disinfectant system to standard system. Perit Dial Int. 1989; 9: 159-163.
  2. Boyce N, Thomson NP, Atkins RC. Management of peritonitis complicating continuous ambulatory peritoneal dialysis: an Australian perspective. Perit Dial Bull. 1987; 7: 93-97. Ref.: https://goo.gl/cgQS5x
  3. Buoncristiani U. The Y set with disinfectant is here to stay. Perit Dial Int. 1989; 9: 149-150. Ref.: https://goo.gl/5tNiGB
  4. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R. Prospective controlled trial of a Y connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet. 1983; 2: 642-644. Ref.: https://goo.gl/8B7FFo
  5. Gokal R. CAPD overview. Perit Dial Int. 1996; 16: S13-S18. Ref.: https://goo.gl/znekyt
  6. Digenis GE, Abraham G, Savin E, Blake P, Dombros N, et al. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1990; 10: 45-47. Ref.: https://goo.gl/oQ4enB
  7. Bailie GR, Eisele G. Vancomycin in peritoneal dialysis associated peritonitis. Semin Dial. 1996; 9: 417-423.
  8. Manley HJ, Bailie GR, Frye RF, McGoldrick MD. Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients. Perit Dial Int 2001; 21: 378-385. Ref.: https://goo.gl/E1tty9
  9. Bastani B, Spyker DA, Westervelt Jr FB. Peritoneal absorption of vancomycin during and after resolution of peritonitis in continuous ambulatory peritoneal dialysis. Perit Dial Int. 1988; 8: 135-136. Ref.: https://goo.gl/Pxjsw3
  10. Bunke CM, Aronoff GA, Brier ME, Sloan RS, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983; 34: 631-637. Ref.: https://goo.gl/XTIRfZ
  11. Pancorbo S, Comty C. Peritoneal transport of vancomycin in four patients undergoing continuous ambulatory peritoneal dialysis. Nephron. 1982; 31: 37-39. Ref.: https://goo.gl/VCw8eT
  12. Mulhern JF, Braden GL, O'Shea MH, Madden RL, Lipkowitz GS, et al. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis. 1995; 25: 611-615. Ref.: https://goo.gl/Fe13vA
  13. Barone RJ, Alvarez Quiroga M, Ferraro J, Locatelli A, De Benedetti L. Exit Site Infection and Peritonitis. In Current Concepts in Peritoneal Dialysis. K. Ota et al. Editors. 1992. Elsevier Science Publishers p. 413-418.
  14. Vas S, Bargman J, Oreopoulos DG. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int. 1997; 17: 91-94. Ref.: https://goo.gl/hLkCI4
  15. Troidle LK, Kliger AS, Finkelstein FO. Challenges of managing CPD-associated peritonitis. Perit Dial Int. 1999; 19: 315-318.
  16. Mason NA, Zhang T, Messana JM. Methicllin-resistance patterns associated with peritonitis in a university-based peritoneal dialysis center. Perit Dial Int. 1999; 19: 483-486. Ref.: https://goo.gl/xVB4tk
  17. Hashimoto H, Inoue M, Hayashi I. A survey of Staphylococcus Aureus for typing and drug- resistance in various areas of Japan during1992 and 1993. Jpn J Antibiot. 1994; 47: 618-626. Ref.: https://goo.gl/keJGYc
  18. Onozato ML, Texeira Caramori JC, Barretti P. Initial treatment of CAPD peritonitis: Poor response with association of cefazolin and amikacin. Perit Dial Int. 1999; 19: 88-89. Ref.: https://goo.gl/aJnU3d
  19. Lai M-N, Kao M-T, Chen C-C, Cheung S-Y, Chung W-K. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int. 1997; 17: 87-89. Ref.: https://goo.gl/KHdbEn
  20. Flanigan MJ, Lim VS. Initial treatment of dialysis associated peritonitis: A controled trial of vancomycin versus cefazolin. Perit Dial Int. 1991; 11: 31-37. Ref.: https://goo.gl/Ddx3qh
  21. Brown EA, Goldberg LC, Clemenger M, Azadian B. Effective treatment of peritonitis using a once-daily vanomycin-free regime in CAPD and APD (Abstract). Perit Dial Int. 1999; 19: 30.
  22. Krothapalli RK, Senekjian HO, Ayus JC. Efficacy of intravenous vancomycin in the treatment of gram- positive peritonitis in long-term peritoneal dialysis. Am J Med. 1983; 75: 345-348. Ref.: https://goo.gl/p30HRq
  23. Obermiller LE, Tzamaloukas AH, Leymon P, Avasthi PS. Intravenous vancomycin as initial treatment for gram positive peritonitis in patients on chronic peritoneal dialysis. Clin Nephrol. 1985; 24: 256-260. Ref.: https://goo.gl/FKl2kW
  24. Vargemezis V, Pasadakis P, Thodis H, Coucudis P, Peihaberis P, et al. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Adv Perit Dial. 1989; 5: 128-129. Ref.: https://goo.gl/CxjeXf
  25. Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev. 2014; 4. Ref.: https://goo.gl/2nFCe8
  26. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Adult peritoneal dialysis related-peritonitis treatment recommendations: 2000 Update. Perit Dial Int. 2000; 20: 396-411. Ref.: https://goo.gl/4EO8aD
  27. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, et al. Peritoneal ISPDDialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010; 30: 393-423. Ref.: https://goo.gl/0sN2ue
  28. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, et al. ISPD peritonitis recommendations: 2016 Update on prevention and treatment. Perit Dial Int. 2016; 36: 481-508. Ref.: https://goo.gl/6j2oz6

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?